Companies/Rapid Dose Therapeutics Corp.

Company profile

Rapid Dose Therapeutics Corp.

OTC: RDTCF · Healthcare · Biotechnology

Canadian filerHQ Burlington, ONReports USD

#790 of 1,394 Healthcare companies by revenue72nd-percentile growth

EA Score

38D

FH 29DQ —GM 67SS 36

v0.1 · 45/100 weight · provisional

↑ 3-yr revenue growth, revenue growth (YoY) · ↓ Piotroski F, balance-sheet leverage

Methodology →

Revenue TTM

$2.0M

Rev growth YoY (TTM)

+33.0%

Net income (FY)

-$2.4M

Employees

Market cap

$10.5M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$2.0M2.8M CAD2026

Net income-$2.4M-3.4M CAD2026

Operating income-$1.2M-1.7M CAD2026

Total assets$2.4M3.3M CAD2026

Liabilities$7.7M10.5M CAD2026

Equity-$5.3M-7.2M CAD2026

Revenue trend

FY2019 – FY2026 · USD

FY19

$76.6k

FY20

$566.0k

FY21

$1.4M

FY22

$546.9k

FY23

$755.5k

FY24

$1.5M

FY25

$2.0M

FY26

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Rapid Dose Therapeutics Corp. booked $2.0M in FY2026 revenue, growing 33% year over year — faster than most Healthcare companies we track, at a -122.2% net margin.

Peers · Healthcare

Nanalysis Scientific Corp.58C Cocrystal Pharma, Inc.31D Bio Essence Corporation52D HealthLynked Corp.35D

Key facts

CEOMark Andrew Upsdell

SectorHealthcare

IndustryBiotechnology

HeadquartersBurlington, ON

ExchangeOTC: RDTCF

Employees12

IPO date2019-09-27

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.